Viewing Study NCT06851858


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-04-09 @ 10:34 AM
Study NCT ID: NCT06851858
Status: RECRUITING
Last Update Posted: 2025-09-11
First Post: 2025-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module